OC

Octagon Capital

North America, New York, United States, New York

Description

Octagon Capital is an investment firm.

Investor Profile

Octagon Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Medical, Pharmaceutical, Therapeutics.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Octagon Capital frequently co-invest with?

INCE Capital
Asia, Shandong, China, Pudong
Co-Investments: 1
TF Capital
Asia, Shandong, China, Pudong
Co-Investments: 1
LongRiver Investments
Asia, Shanghai, China, Xuhui
Co-Investments: 1
3SBio Inc.
Asia, Liaoning, China, Shenyang
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
EV
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Octagon Capital?

Allorion Therapeutics

Natick, Massachusetts, United States

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

MedicalPharmaceuticalTherapeutics
Series BMar 9, 2023
Amount Raised: $50,000,000